DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $337,000 | -51.6% | 9,913 | -27.0% | 0.02% | -17.4% |
Q3 2020 | $697,000 | -62.8% | 13,580 | -56.8% | 0.02% | -52.1% |
Q2 2020 | $1,875,000 | +192.5% | 31,402 | +101.8% | 0.05% | +182.4% |
Q1 2020 | $641,000 | -44.7% | 15,561 | -16.4% | 0.02% | +6.2% |
Q4 2019 | $1,159,000 | – | 18,617 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $18,687,872 | 15.44% |
Redmile Group, LLC | 5,582,105 | $86,243,522 | 3.74% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,218,638 | $80,627,957 | 1.80% |
BRAIDWELL LP | 3,241,351 | $50,078,873 | 1.65% |
Parkman Healthcare Partners LLC | 491,772 | $7,597,877 | 1.65% |
Sunesis Advisors, LLC | 96,299 | $1,487,820 | 1.07% |
ARMISTICE CAPITAL, LLC | 4,100,000 | $63,345,000 | 0.91% |
Deep Track Capital, LP | 1,363,201 | $21,061,455 | 0.86% |
AlphaCentric Advisors LLC | 72,500 | $1,120,125 | 0.77% |
Ikarian Capital, LLC | 174,510 | $2,696,179 | 0.61% |